Baystate Business: Pear Therapeutics (Radio) – Bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Americas+1 212 318 2000
EMEA+44 20 7330 7500
Asia Pacific+65 6212 1000
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Americas+1 212 318 2000
EMEA+44 20 7330 7500
Asia Pacific+65 6212 1000
Tom Moroney, Joe Shortsleeve, Kim Carrigan, Janet Wu and Ann Mostue are joined by top decision makers from local business and finance to politics and technology, along with Bloomberg reporters covering the latest stories in Boston, the Bay State, and beyond.
Tom Moroney, Joe Shortsleeve, Kim Carrigan, Janet Wu and Ann Mostue are joined by top decision makers from local business and finance to politics and technology, along with Bloomberg reporters covering the latest stories in Boston, the Bay State, and beyond.
A Boston company rang the Nasdaq opening bell on Friday. Pear Therapeutics went public in December. Bloomberg's Janet Wu sits down with CEO Corey McCann to talk about the IPO and their development of Prescription Digital Therapeutics.
Jan 07, 2022
Where to Listen:
